Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
DI ›
DIAFERT
Trademark search for:
DIAFERT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-07-31 — Application filed
2020-08-04 — Application filed
2020-08-31 — Application filed
2020-11-19 — Final disposition recorded
2020-11-19 — Final disposition recorded
2020-11-19 — Assigned to examiner
2020-11-19 — Final disposition recorded
2021-06-03 — Examiners amendment -written
2021-06-03 — Approved for pub - principal register
2021-06-03 — Examiners amendment e-mailed
2021-06-03 — Notification of examiners amendment e-mailed
2021-06-03 — Examiner's amendment entered
2021-06-11 — Teas petition to director received
2021-06-11 — Petition to revive-received
2021-06-16 — Notification of notice of publication e-mailed
2021-06-17 — Assigned to petition staff
2021-07-06 — Teas response to petition deficiency received
2021-07-06 — Published for opposition
2021-07-06 — Withdrawn from issue - petitions office request
2021-07-06 — Official gazette publication confirmation e-mailed
2021-07-06 — Incomplete petition notice mailed
2021-08-06 — Approved for pub - principal register
2021-08-06 — Petition granted - response received
2021-08-06 — Previous allowance count withdrawn
2021-08-06 — Notice of revival - e-mailed
2021-08-06 — Assigned to lie
2021-08-09 — Teas/email correspondence entered
2021-08-09 — Correspondence received in law office
2021-08-11 — Attorney review completed
2021-08-11 — Approved for pub - principal register
2021-08-11 — Previous allowance count withdrawn
2021-08-17 — Assigned to lie
2021-08-18 — Law office publication review completed
2021-09-01 — Notification of notice of publication e-mailed
2021-09-21 — Published for opposition
2021-09-21 — Official gazette publication confirmation e-mailed
2021-11-16 — Noa e-mailed - sou required from applicant
2022-06-20 — Application abandoned
2022-06-20 — Final status recorded
2022-06-21 — Application abandoned
Owner Information
Odyssea Pharma SPRL
Odyssea Pharma SPRL
Correspondent
Matthew O. Brady ALLERGAN, INC.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
